SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ — CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ — CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075

CJ BIO Publishes Clinical Study on BiomeNrich™ POST SZ075, a Postbiotic Ingredient Demonstrating Skin Improvement Benefits

2026/02/26 19:15
Okuma süresi: 4 dk

SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ — CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075, in an international peer-reviewed journal. The study strengthens the scientific foundation of the ingredient and supports its positioning as a science-based inner beauty solution.

Growing Importance of Scientific Validation in the Inner Beauty Market

The global beauty and personal care market is rapidly shifting toward “Beauty from within” approaches that improve skin condition through internal health support. In particular, the gut-skin axis has emerged as a key biological pathway linking gut microbiota to skin health, driving increased research into probiotic and postbiotic-based ingestible skincare solutions.

At the same time, consumers increasingly seek objective and measurable evidence addressing visible skin concerns such as UV-induced photoaging, barrier impairment, dryness, roughness, and loss of elasticity. As a result, clinically validated biomarkers and instrumental assessments have become critical in substantiating functional ingredient claims.

CJ BIO’s Science-Based Solution: BiomeNrich™ POST SZ075

BiomeNrich™ POST SZ075 is a postbiotic ingredient within CJ BIO’s Condition-Specific biotics solution brand, BiomeNrich™. It is a 100% plant-based postbiotic produced by fermenting rice germ using Latilactobacillus sakei, a strain originally isolated from kimchi. The ingredient is positioned to support Sleep & Skin Health, developed based on the gut–skin axis concept for inner beauty and mental wellness applications.

The newly published study evaluated the ingredient’s mechanisms of action in improving skin health and influencing skin-related biomarkers. Findings demonstrated significant modulation of key markers associated with barrier integrity, hydration, and wrinkle appearance, including reductions in wrinkle severity and transepidermal water loss (TEWL), alongside increases in skin elasticity and dermal density.

Dual-Action Efficacy of BiomeNrich™ POST SZ075 for Skin Health

A clinical study (n=111, 12 weeks, 500 mg/day) published in Food Science and Biotechnology (2025) confirms the dual functionality of BiomeNrich™ POST SZ075 in combating UV-induced wrinkles and enhancing hydration.

I. Skin wrinkle and roughness

Compared to the placebo, the test group showed significant resilience against UV-induced damage:

  • 1,140% improvement in wrinkle parameters around the eyes.
  • 614% increase in skin elasticity.
  • 172% increase in dermal density

II. Skin hydration and Transepidermal Water Loss

The study also demonstrated improvements in hydration-related and barrier-related parameters:

  • 1,872% decrease in Transepidermal Water Loss (TEWL)
  • 497% improvement in skin roughness and 280% reduction in desquamation.
  • 309% increase in skin moisture content.

Detailed research data on BiomeNrich™ POST SZ075 can be found in CJ BIO’s Nutrition Insight article.
https://na2.hubs.ly/H03W1K20 

Differentiation Through Integrated Evidence

CJ BIO established a multi-layered validation framework for BiomeNrich™ POST SZ075, encompassing in vitro, in vivo, and human clinical studies. This stepwise research design enables mechanistic verification alongside measurable clinical outcomes, strengthening scientific credibility. This integrated validation framework enables brand partners to reference both mechanistic insights and clinical findings when developing product concepts.

In addition to the published clinical study on skin health, CJ BIO has also conducted research exploring sleep-related benefits of BiomeNrich™ POST SZ075, supporting its potential relevance across multiple wellness applications. As a postbiotic ingredient, BiomeNrich™ POST SZ075 offers formulation stability advantages compared to live probiotics, which may facilitate broader product development possibilities.

CJ BIO stated, “This study provides scientific evidence that postbiotics can contribute to skin health. CJ BIO will continue expanding its portfolio of science-backed biotics and functional ingredients to deliver differentiated solutions in the inner beauty market.”

About CJ BIO

CJ BIO is the biotechnology business unit of CJ CheilJedang, leveraging over 70 years of fermentation expertise to deliver functional ingredients and solutions for the food, taste, nutrition, and health industries. CJ BIO is committed to providing sustainable, science-validated bio-solutions that enhance quality of life for customers and consumers worldwide.

Contact Information

Media Inquiries:
CJ BIO
Email: cjbio_brand@cj.net 
Website: https://na2.hubs.ly/H03W1JT0 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cj-bio-publishes-clinical-study-on-biomenrich-post-sz075-a-postbiotic-ingredient-demonstrating-skin-improvement-benefits-302698219.html

SOURCE CJ CheilJedang

Piyasa Fırsatı
BIO Protocol Logosu
BIO Protocol Fiyatı(BIO)
$0.02267
$0.02267$0.02267
+0.84%
USD
BIO Protocol (BIO) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen crypto.news@mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

MetaMask Unveils US Payment Card With Mastercard and On-Chain Rewards

MetaMask Unveils US Payment Card With Mastercard and On-Chain Rewards

MetaMask launches a US payment card with Mastercard, offering on-chain rewards and a metal card option enabled by Baanx and CompoSecure. MetaMask has introduced
Paylaş
LiveBitcoinNews2026/02/27 13:00
Pi Network ARC-314 Update: Building a Decentralized Fortress with 421,000+ Nodes

Pi Network ARC-314 Update: Building a Decentralized Fortress with 421,000+ Nodes

    Pi Network continues to advance its mission to create a truly decentralized financial ecosystem with the AR
Paylaş
Hokanews2026/02/27 13:46
UK and US Seal $42 Billion Tech Pact Driving AI and Energy Future

UK and US Seal $42 Billion Tech Pact Driving AI and Energy Future

The post UK and US Seal $42 Billion Tech Pact Driving AI and Energy Future appeared on BitcoinEthereumNews.com. Key Highlights Microsoft and Google pledge billions as part of UK US tech partnership Nvidia to deploy 120,000 GPUs with British firm Nscale in Project Stargate Deal positions UK as an innovation hub rivaling global tech powers UK and US Seal $42 Billion Tech Pact Driving AI and Energy Future The UK and the US have signed a “Technological Prosperity Agreement” that paves the way for joint projects in artificial intelligence, quantum computing, and nuclear energy, according to Reuters. Donald Trump and King Charles review the guard of honour at Windsor Castle, 17 September 2025. Image: Kirsty Wigglesworth/Reuters The agreement was unveiled ahead of U.S. President Donald Trump’s second state visit to the UK, marking a historic moment in transatlantic technology cooperation. Billions Flow Into the UK Tech Sector As part of the deal, major American corporations pledged to invest $42 billion in the UK. Microsoft leads with a $30 billion investment to expand cloud and AI infrastructure, including the construction of a new supercomputer in Loughton. Nvidia will deploy 120,000 GPUs, including up to 60,000 Grace Blackwell Ultra chips—in partnership with the British company Nscale as part of Project Stargate. Google is contributing $6.8 billion to build a data center in Waltham Cross and expand DeepMind research. Other companies are joining as well. CoreWeave announced a $3.4 billion investment in data centers, while Salesforce, Scale AI, BlackRock, Oracle, and AWS confirmed additional investments ranging from hundreds of millions to several billion dollars. UK Positions Itself as a Global Innovation Hub British Prime Minister Keir Starmer said the deal could impact millions of lives across the Atlantic. He stressed that the UK aims to position itself as an investment hub with lighter regulations than the European Union. Nvidia spokesman David Hogan noted the significance of the agreement, saying it would…
Paylaş
BitcoinEthereumNews2025/09/18 02:22